109 related articles for article (PubMed ID: 26181026)
1. Urinary Biomarkers for the Detection and Management of Localized Renal Cell Carcinoma.
Rini BI; Campbell SC
JAMA Oncol; 2015 May; 1(2):212-3. PubMed ID: 26181026
[No Abstract] [Full Text] [Related]
2. Screening for kidney cancer: is there a role for aquaporin-1 and adipophilin?
Grebe SK; Erickson LA
Mayo Clin Proc; 2010 May; 85(5):410-2. PubMed ID: 20435833
[No Abstract] [Full Text] [Related]
3. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
4. Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade.
Morrissey JJ; Mobley J; Song J; Vetter J; Luo J; Bhayani S; Figenshau RS; Kharasch ED
Urology; 2014 Jan; 83(1):256.e9-14. PubMed ID: 24239027
[TBL] [Abstract][Full Text] [Related]
5. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.
Morrissey JJ; Mobley J; Figenshau RS; Vetter J; Bhayani S; Kharasch ED
Mayo Clin Proc; 2015 Jan; 90(1):35-42. PubMed ID: 25572193
[TBL] [Abstract][Full Text] [Related]
6. Urinary KIM-1 and AQP-1 in patients with clear renal cell carcinoma: Potential noninvasive biomarkers.
Mijugković M; Stanojević I; Milović N; Cerović S; Petrović D; Jovanović D; Aleksić P; Kovacević B; Andjelić T; Terzic B; Djukić M; Vojvodić D
Vojnosanit Pregl; 2016 Mar; 73(3):266-72. PubMed ID: 27295912
[TBL] [Abstract][Full Text] [Related]
7. The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma.
Morrissey JJ; Kharasch ED
J Urol; 2013 May; 189(5):1913-20. PubMed ID: 23154208
[TBL] [Abstract][Full Text] [Related]
8. Urinary aquaporin 1 and perilipin 2: Can these novel markers accurately characterize small renal masses and help guide patient management?
Song JB; Morrissey JJ; Mobley JM; Figenshau KG; Vetter JM; Bhayani SB; Kharasch ED; Figenshau RS
Int J Urol; 2019 Feb; 26(2):260-265. PubMed ID: 30467901
[TBL] [Abstract][Full Text] [Related]
9. Urinary biomarkers for the early diagnosis of kidney cancer.
Morrissey JJ; London AN; Luo J; Kharasch ED
Mayo Clin Proc; 2010 May; 85(5):413-21. PubMed ID: 20375178
[TBL] [Abstract][Full Text] [Related]
10. Aquaporin-1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions.
Sreedharan S; Petros JA; Master VA; Ogan K; Pattaras JG; Roberts DL; Lian F; Arnold RS
Dis Markers; 2014; 2014():135649. PubMed ID: 24803718
[TBL] [Abstract][Full Text] [Related]
11. [A tumor marker for renal cell carcinoma: evaluation of urinary S100-alpha protein].
Tanaka J; Takashi M; Mitsuya H; Haimoto H; Kato K
Nihon Hinyokika Gakkai Zasshi; 1987 Dec; 78(12):2051-9. PubMed ID: 3451978
[No Abstract] [Full Text] [Related]
12. Serum and urine biomarkers for human renal cell carcinoma.
Pastore AL; Palleschi G; Silvestri L; Moschese D; Ricci S; Petrozza V; Carbone A; Di Carlo A
Dis Markers; 2015; 2015():251403. PubMed ID: 25922552
[TBL] [Abstract][Full Text] [Related]
13. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
[TBL] [Abstract][Full Text] [Related]
14. Urinary Human Kidney Injury Molecule1- (hKIM1-) is not Increased in Patients with Renal Cell Carcinoma.
Bialek L; Poletajew S; Niemczyk M; Czerwinska K; Nowak M; Sadowska A; Borkowski T; Radziszewski P; Dobruch J; Kryst P
Urol J; 2020 Oct; 17(6):664-666. PubMed ID: 33000456
[TBL] [Abstract][Full Text] [Related]
15. Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer.
Oto J; Plana E; Sánchez-González JV; García-Olaverri J; Fernández-Pardo Á; España F; Martínez-Sarmiento M; Vera-Donoso CD; Navarro S; Medina P
Curr Urol Rep; 2020 Mar; 21(2):11. PubMed ID: 32166474
[TBL] [Abstract][Full Text] [Related]
16. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.
Papale M; Vocino G; Lucarelli G; Rutigliano M; Gigante M; Rocchetti MT; Pesce F; Sanguedolce F; Bufo P; Battaglia M; Stallone G; Grandaliano G; Carrieri G; Gesualdo L; Ranieri E
Oncotarget; 2017 Jun; 8(25):40412-40424. PubMed ID: 28418894
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactive low-molecular-weight epidermal growth factor in urine of patients with renal cell carcinoma.
le Coutre P; Bock S; Jakse G; Petrides PE
Urol Res; 1992; 20(4):293-6. PubMed ID: 1509636
[TBL] [Abstract][Full Text] [Related]
18. Nephrocalcin in patients with renal cell carcinoma.
Nakagawa Y; Netzer M; Michaels EK; Suzuki F; Ito H
J Urol; 1994 Jul; 152(1):29-34. PubMed ID: 8201680
[TBL] [Abstract][Full Text] [Related]
19. Beta-2-glycoprotein-1 and alpha-1-antitrypsin as urinary markers of renal cancer in von Hippel-Lindau patients.
Mandili G; Notarpietro A; Khadjavi A; Allasia M; Battaglia A; Lucatello B; Frea B; Turrini F; Novelli F; Giribaldi G; Destefanis P
Biomarkers; 2018 Mar; 23(2):123-130. PubMed ID: 28004973
[TBL] [Abstract][Full Text] [Related]
20. Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma.
Li G; Zhao A; Péoch M; Cottier M; Mottet N
Urol Oncol; 2017 May; 35(5):294-299. PubMed ID: 28089386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
